Receiver operating characteristics curve analysis of factors predictive of nonresponse to interferon therapy in patients with chronic hepatitis C;Analisis mediante las curvas ROC de los factores predictivos de no respuesta al tratamiento con interferon en pacientes con hepatitis cronica C

Revista Espanola de Enfermedades Digestivas

Volumn 92, Issue 8, 2000, Pages 495-507

  Olaso, V ^a   Cordoba, J ^a   Siles, M S ^a   Molina, J M ^a   Arguello, L ^a   Aguilera, M V ^a   Bastida, G ^a   Lopez Viedma, B ^a   Esteban, R ^a   Berenguer, J ^a   Segovia, M ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Chronic hepatitis C; Hepatitis C virus; Interferon; Receiver operating characteristics curve; Response to treatment

Indexed keywords

FERRITIN; RECOMBINANT ALPHA INTERFERON;

ADULT; ARTICLE; DOSE RESPONSE; DRUG EFFICACY; FEMALE; FOLLOW UP; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; STATISTICAL ANALYSIS;

ADULT; ANTIVIRAL AGENTS; COMPARATIVE STUDY; FEMALE; HEPATITIS C, CHRONIC; HUMAN; INTERFERONS; MALE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; ROC CURVE; TREATMENT FAILURE;

EID: 0033782309     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. National institutes of health consensus development conference panel statement: Management of hepatitis C
2. The treatment of chronic viral hepatitis
3. A French consensus conference on hepatitis C: Screening and treatment
4. Avoiding false positives with PCR
5. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay
6. A proposed system for the nomenclature of hepatitis C viral genotypes
7. Accurate quantification of hepatitis C virus (HCV) RNA from all HCV genotypes bu using branched-DNA technology
8. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis
9. Treatment of chronic hepatitis C with recombinant human interferon-α(2a): Results of a randomized controlled clinical trial
10. Long-term follow-up of patients with chronic hepatitis C treated with different doses of interferon-α(2b)
11. Discrepancy between biochemical and virological responses to interferon-α in chronic hepatitis C
12. Hepatic hepatitis C virus RNA as a predictor of a long-term response to interferon-α therapy
13. Long-term carriage of hepatitis C virus with normal aminotranferase after interferon treatment in patients with chronic hepatitis C
14. Prediction of response during interferon alfa-2b therapy in chronic hepatitis C patients using viral and biochemical characteristic: A comparison
15. Late reactivation of chronic hepatitis C after sustained biochemical response to interferon therapy
16. Factors predictive of the response to interferon in patients with chronic hepatitis C
17. Randomized trial comparing three different regimnes of alpha-2a-interferon in chronic hepatitis C
18. Predictive factors in the response to interferon therapy in chronic hepatitis C
19. A Statistical analysis of predictive factors of response to human lymphoblastoid interferon in patients with chronic hepatitis C
20. Interferon-α for chronic hepatitis C: An analysis of pretreatment clinical predictors of response
21. Response to interferon-α therapy is influenced by the iron content of the liver
22. Factors predictive of response to interferon-α therapy in hepatitis C virus infection
23. Detection of hepatitis C virus by polymerase and response to interferon-α therapy: Relationship to genotipes of hepatitis C virus
24. Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alpha therapy in chronic hepatitis C
25. Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C
26. Quantitation and typing of serum hepatitis C virus RNA in patients with chronic hepatitis C treated with interferon-α
27. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C
28. Changes in serum hepatitis C virus RNA titer and response to interferon therapy in patients with chronic hepatitis C
29. Serum RNA titer at the end of interferon therapy predicts the long-term outcome of treatment
30. Pretreatment viral load and response to prolonged interferon-α course for chronic hepatitis C
31. Factors predictive of a beneficial response to therapy of hepatitis C